Quarterly ResultJun 3, 2026, 07:01 AM
MiniMed Q4 Net Sales $837M, FY26 Sales $3.1B; FY27 Organic Growth 10%
AI Summary
MiniMed Group, Inc. reported strong financial results for its fourth quarter and full fiscal year 2026, with Q4 net sales reaching $837 million, a 15.6% increase as reported and 8.7% organic year-over-year. The company achieved record annual net sales of $3.102 billion, growing 14.2% as reported and 8.0% organic. Key highlights include global launches of MiniMed Flex™, Instinct, and MiniMed Go™ Smart MDI, along with an extended partnership with Abbott. For fiscal year 2027, MiniMed expects approximately 10% organic revenue growth and an adjusted EBITDA margin of 16%.
Key Highlights
- Q4 2026 net sales were $837 million, up 15.6% as reported and 8.7% organic year-over-year.
- Full fiscal year 2026 net sales reached a record $3.102 billion, up 14.2% as reported and 8.0% organic.
- International net sales in Q4 grew 22.4% as reported and 12.2% organic to $599 million.
- Worldwide New Pumps Sold (NPS) increased 7.4% quarter-over-quarter to approximately 42,000 in Q4.
- Worldwide CGM Attachment Rate increased 100 bps quarter-over-quarter to 68% in Q4.
- Launched MiniMed Flex™, MiniMed Go™ Smart MDI, and received CE Mark for Instinct sensor.
- Extended partnership with Abbott to commercialize dual glucose-ketone sensors.
- Fiscal Year 2027 outlook projects approximately 10% organic revenue growth and 16% Adjusted EBITDA margin.
Price Impact
More from MMED